openPR Logo
Press release

Global Bacterial Antigens Market Precise Scenario Covering Trends, Opportunities and Growth Forecast during 2018-2028 / Major Bio-Rad Laboratories, Inc., Creative Diagnostics, Enzo Life Sciences, Inc., The Native Antigen Company Ltd., Jena Bioscience GmbH

01-09-2019 07:36 AM CET | Health & Medicine

Press release from: Fact.MR

Global Bacterial Antigens Market Precise Scenario Covering

Antigens are substances capable of triggering an immune response in a host, by activating lymphocytes or initiating antibody production against the infection. Depending upon whether they enter the human body from outside or originate within the body, these bacterial antigens are classified as foreign or self-antigens, respectively. Among these, self-antigens comprise mutated or overexpressed proteins. However, foreign antigens may include bacteria, parasites, viruses, chemicals and sometimes toxins and proteins found in food products. The epitope or antigenic determinant portion of a bacterial antigen is recognized by antigen specific receptors located on T and B cells. These highly immunogenic antigenic determinants elicit strong immune response and thus, are used to generate antibodies for clinical research purposes. Bacterial antigens in Bacterial Antigens Market are majorly found in distinct formats, such as purified, inactivated pathogens, ascites and antigen carrier conjugates.  

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=1301

A wide range of native state bacterial antigens are in high demand, particularly for vaccine research and in-vitro diagnostics. Standard properties recommended for apt bacterial antigens include higher specificity and sensitivity, reproducible scale-up for bulk quantities, minimal lot-to-lot variation and extended shelf-life. Under product type segment defined for the bacterial antigens market, Chlamydia trachomatis, followed by Clostridium difficile Toxoid A, accounts for a significant revenue share in global bacterial antigens market. Native Chlamydia trachomatis and Helicobacter pylori are commonly recommended bacterial antigens in the bacterial antigens market used to fight various diseases, such as gastritis. These bacterial antigens find applications in various diagnostic techniques, including ELISA, immunoassay, SDS-PAGE, hemagglutination and agglutination test. Major potential end users for bacterial antigens market include hospital associated diagnostic laboratories, diagnostic laboratories and centers and academic and research institutes.

The growing demand for bacterial antigens capable of eliciting a protective immune response against various cancers and infectious diseases is expected to be the major factor driving the growth of the bacterial antigens market over the forecast period. Also, rapid discovery of novel antigens that can trigger a cross-protective immune response in a bacterial pathogen, growing incidences of cancer and infectious diseases and increase in diagnosis of various diseases are some of the factors further expected to drive the revenue growth in global bacterial antigens market. Approval and launch of new bacterial antigens is the other important factor contributing to the growth of the global bacterial antigens market. However, increasing risk of bacterial infection in host might restrain the revenue growth in global bacterial antigens market.

The global market for bacterial antigens is expected to register moderate growth rate over the forecast period on account of an increase in the number of diagnostic tests performed in humans. Different types of bacterial antigens are being introduced in the bacterial antigens market by leading players, such as Bio-Rad Laboratories, Inc. and Creative Diagnostics. Thus, there exists high competition among local and regional players in the bacterial antigens market.  

To know more about the Bacterial Antigens Market Visit the link- https://www.factmr.com/report/1301/bacterial-antigens-market

Among the bacterial antigens type indicated for various diagnostic applications, the Clostridium difficile Toxoid A product segment is expected to lead the global bacterial antigens market over the forecast period. Among the pathogen type segment, inactivated bacterial pathogen will register higher demand from end users as compared to purified pathogens. Diagnostic laboratories and centers are expected to contribute high revenue share to the global bacterial antigens market as these are the most significant platforms for performing diagnostic tests. Hospital associated diagnostic laboratories also account for significant revenue generation.

Bacterial Antigens Market: Regional Outlook

Geographically, the global bacterial antigens market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the leading market in the global bacterial antigens market owing to the rise in number of research applications of bacterial antigens coupled with increased set up of advanced diagnostic laboratories in the region as compared to other regions. The bacterial antigens market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the high presence of domestic players manufacturing bacterial antigens to be used to perform immunoassays and agglutination tests along with increased production of variant bacterial antigens by these key domestic players. Europe is expected to register second largest share in the global bacterial antigens market throughout the forecast period owing to increased presence of bacterial antigen distributors and suppliers across the region.

Bacterial Antigens Market: Key Players

The global bacterial antigens market is highly fragmented owing to the presence of large number of domestic manufacturers. Examples of some of the key players operating in the global bacterial antigens market are Bio-Rad Laboratories, Inc., Creative Diagnostics, Enzo Life Sciences, Inc., The Native Antigen Company Ltd., Jena Bioscience GmbH, QED Bioscience Inc., Ross Southern Laboratories and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=1301

 

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Bacterial Antigens Market Precise Scenario Covering Trends, Opportunities and Growth Forecast during 2018-2028 / Major Bio-Rad Laboratories, Inc., Creative Diagnostics, Enzo Life Sciences, Inc., The Native Antigen Company Ltd., Jena Bioscience GmbH here

News-ID: 1481478 • Views:

More Releases from Fact.MR

NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact.MR Report
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact. …
The global NFC chip market is valued at US$ 1.9 billion in 2023 and is forecasted to surge at a CAGR of 15% to reach a market size of US$ 7.6 billion by the end of 2033. The NFC Chip Industry sales study offers a comprehensive analysis on diverse features including production capacities, NFC Chip demand, product developments, sales revenue generation and NFC Chip market outlook across the globe. market research
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Report
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Repo …
The global canned beans market is valued at US$ 5.65 billion in 2023 and is projected to reach US$ 15 billion by the end of 2033, expanding at a high-value CAGR of 10.3% from 2023 to 2033. The Canned Beans Industry sales study offers a comprehensive analysis on diverse features including production capacities, Canned Beans demand, product developments, sales revenue generation and Canned Beans market outlook across the globe. market research
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% CAGR | Fact.MR
04-25-2024 | Health & Medicine
Fact.MR
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% …
The plasma fractionation market is projected to be valued US$ 32 billion in 2022. Moreover, growth is anticipated to pick up speed at a 7.3% CAGR over the assessment period of 2022-2032 and reach US$ 65 billion. The primary driver of the market's growth is the aging of the global population, which makes people more vulnerable to rare illnesses that call for the usage of blood derivatives. Furthermore, it is anticipated
Chemical Pulp Market Predicted to Garner US$ 19.5 Billion by 2033, At CAGR 7.4% | Fact.MR
Chemical Pulp Market Predicted to Garner US$ 19.5 Billion by 2033, At CAGR 7.4% …
According to the most recent data from market research and competitive intelligence provider Fact.MR, the global chemical pulp market is projected to grow at a compound annual growth rate (CAGR) of 7.4% between 2023 and 2033, reaching US$ 19.5 billion by the end of 2033. Large tanks called digesters are used to combine chemicals and wood chips to create chemical pulp. Lignin, which helps hold cellulose fibers together without seriously harming

All 5 Releases


More Releases for Antigen

New HGH Saliva Antigen Covid Test gamechanger
An Austrian company HGH Disinfection und Cosmetique Gmbh, based in 9020 Klagenfurt created with a Korean partner a unique antigen salvia test unit which is so simple that anybody can use it. Till now mass testing was nasal stick by government and doctors. Now this new test unit can be used by everybody without a scarry stick in the nose and a result with 95% is ready in 10
p53 Antigen Modulators Therapeutics- Pipeline Analysis 2018 |
p53 is the tumor suppressor transcription factor that activates to various stimulus, including uncontrolled cell proliferation, oncogene over-expression, and DNA damage. p53 antigen modulators helps in preventing cancer development through regulation of cell cycle and apoptosis. Download the sample report @ https://www.pharmaproff.com/request-sample/1195 Thus, new opportunities in cancer immunotherapy are expected to develop better drug candidates targeting p53, with complete understanding of interactions between p53 and the immune system, to avoid various
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Anti …
ReportsWorldwide has announced the addition of a new report title Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) also
CancerTestis Antigen 1 (Autoimmunogenic CancerTestis Antigen NY ESO 1 or CancerT …
ReportsWorldwide has announced the addition of a new report title CancerTestis Antigen 1 (Autoimmunogenic CancerTestis Antigen NY ESO 1 or CancerTestis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) -
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Anti …
Market Research Hub (MRH) added a new research report to its vast database titled “Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) Pipeline Review, H2 2017” targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Carcinoembryonic Antigen Related Cell Adhesion
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cance …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2017”. Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Cancer/Testis